PLx Pharma Inc. just provided an update on activist position in Dipexium Pharmaceuticals, Inc.

PLx Pharma Inc. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13D. In the filing, it appears as though PLx Pharma Inc. claims to own 4,414,270 shares. This represents 39.63% of Dipexium Pharmaceuticals, Inc..

Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback